Bringing AI into GxP Operations: Real-World Execution
This LinkedIn Live session explored practical AI adoption across GxP-regulated IT, quality, and manufacturing, focusing on real-world execution while maintaining compliance and inspection readiness.
AI in GxP : Strategy to Execution
Speakers discussed how AI-driven analytics, automation, and intelligent agents are being applied within regulated operations to enhance quality processes and compliance workflows. The conversation emphasized that clearly defined intended use, strong governance, and ongoing human oversight are critical to scaling AI without compromising regulatory expectations.
Real-World Impact
The session highlighted measurable outcomes from AI adoption across regulated environments, including faster validation and documentation workflows, improved audit and inspection readiness through enhanced traceability, and more effective batch review, deviation analysis, and risk-based decision-making. The discussion reinforced AI’s role as a co-pilot, supporting human judgment while strengthening GxP compliance.
Event at a Glance
624+
Registrations
534+
Unique Viewers
3652
Minutes viewed
Featured Voices
Visionaries who led the conversation.
Nagesh Nama
Chief Executive Officer, xLM
Bob Buhlmann
Head of Quality, Digital & Computer Strategy, AstraZeneca
45 Minutes ofPractical Insights
January 29, 2026
Full access session recording available on demand.
45 Minutes of Content
Recorded LinkedIn Live session sharing practical AI adoption insights for GxP-regulated environments.
This LinkedIn Live session brought together industry leaders to explore how Artificial Intelligence is being practically applied across pharma IT, quality, and manufacturing operations within GxP-regulated environments. The discussion moved beyond AI hype to focus on real execution, covering validation, governance, inspection readiness, and human oversight. Speakers shared hands-on insights into how AI-driven analytics, automation, and intelligent agents can enhance compliance workflows, improve decision-making, and deliver measurable operational value while meeting regulatory expectations.
Detailed Event Overview
The LinkedIn Live event “GxP in the Age of AI: Real-World Perspectives from Pharma IT & Manufacturing” explored how life sciences organizations are practically adopting Artificial Intelligence within GxP-regulated environments. The session focused on moving beyond experimental use cases to real-world execution, showcasing how AI supports quality systems, manufacturing operations, and compliance workflows while remaining inspection-ready and aligned with regulatory expectations.
AI Adoption in GxP Operations
Explore how organizations are moving from AI experimentation to practical deployment across regulated manufacturing and Quality environments.
Governance & Risk Management
Understand the governance frameworks, oversight practices, and risk controls required for responsible AI implementation.
Compliance & Inspection Readiness
Learn how AI initiatives can support operational improvement while maintaining compliance, validation expectations, and inspection preparedness.
Operational Impact & Value Creation
Discover how AI can improve process visibility, decision-making, efficiency, and measurable business outcomes across regulated operations.